Filtra per Last updated date ScegliereDopoPrimaFrom - To Data Data di conclusione Questa settimana Questo mese Ultima settimana Ultimo mese Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationResearch and developmentMedicine shortagesBiosimilarsSMEAntimicrobial resistanceGovernanceBrexitQuality of medicinesCorporateGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationMedical devicesScientific adviceMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorParallel distributionProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety Yes Leave this field blank Filtra Risultati (3786) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank EMA starts rolling review of Valneva’s COVID-19 vaccine (VLA2001) 2 Dicembre 2021 News Human COVID-19 Vaccines Increase in manufacturing capacity for COVID-19 vaccine from AstraZeneca 1 Dicembre 2021 News Human COVID-19 Vaccines Comirnaty COVID-19 vaccine: EMA recommends approval for children aged 5 to 11 25 Novembre 2021 News Human COVID-19 Vaccines A vision for use of real-world evidence in EU medicines regulation 24 Novembre 2021 News Human Corporate EMA receives application for marketing authorisation for Lagevrio (molnupiravir) for treating patients with COVID 19 23 Novembre 2021 News Human COVID-19 Medicines 2011-2020: More than 40% decrease in sales of antimicrobials for use in animals 23 Novembre 2021 News Veterinary Antimicrobial resistance EMA evaluating data on booster dose of COVID-19 Vaccine Janssen 22 Novembre 2021 News Human COVID-19 Vaccines EMA issues advice on use of Lagevrio (molnupiravir) for the treatment of COVID-19 19 Novembre 2021 News Human COVID-19 Medicines EMA starts review of Paxlovid for treating patients with COVID-19 19 Novembre 2021 News Human COVID-19 Medicines European Antibiotic Awareness Day: Fighting the silent pandemic 18 Novembre 2021 News Human Veterinary Corporate Antimicrobial resistance 1 … 49 50 51 52 53 Page 53 of 379 54 55 56 57 … 379
EMA starts rolling review of Valneva’s COVID-19 vaccine (VLA2001) 2 Dicembre 2021 News Human COVID-19 Vaccines
Increase in manufacturing capacity for COVID-19 vaccine from AstraZeneca 1 Dicembre 2021 News Human COVID-19 Vaccines
Comirnaty COVID-19 vaccine: EMA recommends approval for children aged 5 to 11 25 Novembre 2021 News Human COVID-19 Vaccines
A vision for use of real-world evidence in EU medicines regulation 24 Novembre 2021 News Human Corporate
EMA receives application for marketing authorisation for Lagevrio (molnupiravir) for treating patients with COVID 19 23 Novembre 2021 News Human COVID-19 Medicines
2011-2020: More than 40% decrease in sales of antimicrobials for use in animals 23 Novembre 2021 News Veterinary Antimicrobial resistance
EMA evaluating data on booster dose of COVID-19 Vaccine Janssen 22 Novembre 2021 News Human COVID-19 Vaccines
EMA issues advice on use of Lagevrio (molnupiravir) for the treatment of COVID-19 19 Novembre 2021 News Human COVID-19 Medicines
EMA starts review of Paxlovid for treating patients with COVID-19 19 Novembre 2021 News Human COVID-19 Medicines
European Antibiotic Awareness Day: Fighting the silent pandemic 18 Novembre 2021 News Human Veterinary Corporate Antimicrobial resistance